Access cutting-edge advanced malignant solid neoplasm treatment through this clinical trial at a research site in Everett. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Everett location
Preparing your pre-screening questions…
Access advanced malignant solid neoplasm specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related advanced malignant solid neoplasm treatment provided free
Check if you qualify for this advanced malignant solid neoplasm clinical trial in Everett, WA
No-Cost Study Care
Local to Everett
Convenient for WA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This clinical trial studies whether telephone-based coaching sessions, Talking About Cancer (TAC), work to improve engagement in advance care planning (ACP) in patients with cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) and their support person. Participation in ACP, which includes having end of life (EOL) care conversations and completing advance directives (e.g., living will, health care proxy, do not resuscitate order), improves quality EOL care. Despite this, less than half of patients with advanced cancer have EOL care conversations or complete advance directives. TAC coaching sessions are delivered by a social worker over the phone. They are designed to help patients and their support person communicate about ACP, manage the distress these conversations can cause, and participate in the process of ACP with a clear action plan of having goals-of-care conversations and completing advance directives. This may be an effective way to improve ACP participation in advanced cancer patients and their support person.
Sponsor: Fred Hutchinson Cancer Center
Yes, this clinical trial (NCT07141407) has an active research site in Everett, WA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for advanced malignant solid neoplasm treatment options in Everett, WA, this clinical trial (NCT07141407) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Everett research site is actively enrolling participants for this clinical trial. You'll receive care from experienced advanced malignant solid neoplasm specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all advanced malignant solid neoplasm clinical trials near you to find additional studies recruiting in your area.
See all alzheimers disease clinical trials recruiting in Everett — not just this study.
Browse Alzheimers Disease Trials in Everett →